This company listing is no longer active
Amedisys (ADY) Stock Overview
Provides healthcare services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
ADY Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Amedisys, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$84.50 |
| 52 Week High | US$90.50 |
| 52 Week Low | US$78.00 |
| Beta | 0.90 |
| 1 Month Change | 3.05% |
| 3 Month Change | 1.20% |
| 1 Year Change | -3.43% |
| 3 Year Change | -28.39% |
| 5 Year Change | -57.32% |
| Change since IPO | 392.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| ADY | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 1.2% | 3.8% | 0.5% |
| 1Y | -3.4% | 2.3% | -0.9% |
Return vs Industry: ADY underperformed the German Healthcare industry which returned 34.2% over the past year.
Return vs Market: ADY underperformed the German Market which returned 18.1% over the past year.
Price Volatility
| ADY volatility | |
|---|---|
| ADY Average Weekly Movement | 2.2% |
| Healthcare Industry Average Movement | 5.1% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in DE Market | 12.5% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: ADY has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: ADY's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 19,000 | Richard Ashworth | www.amedisys.com |
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.
Amedisys, Inc. Fundamentals Summary
| ADY fundamental statistics | |
|---|---|
| Market cap | €2.85b |
| Earnings (TTM) | €73.52m |
| Revenue (TTM) | €2.06b |
Is ADY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ADY income statement (TTM) | |
|---|---|
| Revenue | US$2.40b |
| Cost of Revenue | US$1.36b |
| Gross Profit | US$1.04b |
| Other Expenses | US$952.04m |
| Earnings | US$85.63m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.60 |
| Gross Margin | 43.19% |
| Net Profit Margin | 3.56% |
| Debt/Equity Ratio | 26.4% |
How did ADY perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/14 05:40 |
| End of Day Share Price | 2025/08/14 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Amedisys, Inc. is covered by 15 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Gillmor | Baird |
| Steven Valiquette | Barclays |
| Sarah James | Barclays |